COLUMN GROUP L P Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for COLUMN GROUP L P.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of COLUMN GROUP L P. COLUMN GROUP L P is a 10% Owner in NGM BIOPHARMACEUTICALS INC ($NGM) and a Director in NGM BIOPHARMACEUTICALS INC ($NGM) and a 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and a 10% Owner in Immune Design Corp. ($IMDZ) and a 10% Owner in Nurix Therapeutics, Inc. ($NRIX).
Address: 1700 OWENS STREET, SUITE 500 SAN FRANCISCO 94158 CA
Companies in which COLUMN GROUP L P is an Insider
CONSTELLATION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of COLUMN GROUP L P: 10% Owner
Holdings: 99,155 shares
Latest Transaction: Feb 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNE DESIGN CORP.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of COLUMN GROUP L P: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 02 2019
$IMDZ Market Capitalization: $132.13M
$IMDZ Previous Close: $5.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NGM BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of COLUMN GROUP L P: Director, 10% Owner
Holdings: 1,799,430 shares
Latest Transaction: Sep 03 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nurix Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of COLUMN GROUP L P: 10% Owner
Holdings: 1,394,333 shares
Latest Transaction: May 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of COLUMN GROUP L P
Sentiment: All, CNST, IMDZ, NGM, NRIX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 7,752 | 0 | 48,406 | 40.7 K to 48.4 K (+19.07 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 17,829 | 0 | 139,383 | 121.6 K to 139.4 K (+14.67 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 17,829 | 0 | 134,010 | 116.2 K to 134 K (+15.35 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Sell | J | 0.00 | 49,689 | 0 | 0 | 49.7 K to 0 (-100.00 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 49,689 | 0 | 49,689 | 0 to 49.7 K |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 989,000 | 2 M to 989 K (-50.28 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 30,347 | 0 | 40,654 | 10.3 K to 40.7 K (+294.43 %) |